Howard Lee - Jun 3, 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Jun 3, 2024
Transactions value $
-$24,341
Form type
4
Date filed
6/5/2024, 08:10 PM
Previous filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Award $0 +3.08K +2.12% $0.00 148K Jun 3, 2024 Direct F1
transaction AMPH Common Stock Tax liability -$24.3K -579 -0.39% $42.04 148K Jun 5, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Award $0 +6.86K $0.00 6.86K Jun 3, 2024 Common Stock 6.86K $42.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 3, 2025.
F2 The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F3 All of the shares subject to the option vest on June 3, 2025.